Optical biosensors for the detection of rheumatoid arthritis (RA) biomarkers: a comprehensive review
A comprehensive review of optical biosensors for the detection of biomarkers associated
with rheumatoid arthritis (RA) is presented here, including microRNAs (miRNAs), C-reactive …
with rheumatoid arthritis (RA) is presented here, including microRNAs (miRNAs), C-reactive …
Myeloid‐derived microRNAs, miR‐223, miR27a, and miR‐652, are dominant players in myeloid regulation
AB Gilicze, Z Wiener, S Tóth, E Buzás… - BioMed research …, 2014 - Wiley Online Library
In the past few years expanding knowledge has been accumulated about the role of
microRNAs (miRNAs) not only in hematopoiesis and cancer, but also in inflammatory and …
microRNAs (miRNAs) not only in hematopoiesis and cancer, but also in inflammatory and …
Harnessing an inhibitory role of miR-16 in osteogenesis by human mesenchymal stem cells for advanced scaffold-based bone tissue engineering
MicroRNA (miRNA) therapeutics is increasingly being developed to either target bone-
related diseases such as osteoporosis and osteoarthritis or as the basis for novel bone …
related diseases such as osteoporosis and osteoarthritis or as the basis for novel bone …
Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders
C Lopez-Pedrera, N Barbarroja… - International Journal of …, 2020 - mdpi.com
Rheumatoid Arthritis (RA), Systemic lupus erythematosus (SLE) and antiphospholipid
syndrome (APS) are the systemic autoimmune diseases (SADs) most associated with an …
syndrome (APS) are the systemic autoimmune diseases (SADs) most associated with an …
Decreased MiR-128-3p alleviates the progression of rheumatoid arthritis by up-regulating the expression of TNFAIP3
Z Xia, F Meng, Y Liu, Y Fang, X Wu, C Zhang… - Bioscience …, 2018 - portlandpress.com
Background: Rheumatoid arthritis (RA) is a inflammatory disease that characterized with the
destruction of synovial joint, which could induce disability. Inflammatory response mediated …
destruction of synovial joint, which could induce disability. Inflammatory response mediated …
MicroRNA expression differences in blood-derived CD19+ B cells of methotrexate treated rheumatoid arthritis patients
F Heinicke, X Zhong, ST Flåm, J Breidenbach… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a complex disease with a wide range of underlying
susceptibility factors. Recently, dysregulation of microRNAs (miRNAs) in RA have been …
susceptibility factors. Recently, dysregulation of microRNAs (miRNAs) in RA have been …
miR-22 inhibits synovial fibroblasts proliferation and proinflammatory cytokine production in RASF via targeting SIRT1
C Zhang, L Fang, X Liu, T Nie, R Li, L Cui, J Wang, Y Ji - Gene, 2020 - Elsevier
Background/aims Rheumatoid arthritis synovial fibroblasts (RASF) play an essential role in
the pathogenesis of rheumatoid arthritis (RA). This study aimed to investigate the biological …
the pathogenesis of rheumatoid arthritis (RA). This study aimed to investigate the biological …
The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatment
Extracellular vesicles (EVs) are membranous vesicles released from almost all type of cells
including cancer cells. EVs transfer their components, such as microRNAs (miRNAs) …
including cancer cells. EVs transfer their components, such as microRNAs (miRNAs) …
The function of ncRNAs in rheumatic diseases
W Chen, D Liu, QZ Li, H Zhu - Epigenomics, 2019 - Taylor & Francis
Rheumatic diseases are a group of chronic heterogeneous autoimmune disorders
characterized by abnormal regulation of the innate and adaptive immune systems. Despite …
characterized by abnormal regulation of the innate and adaptive immune systems. Despite …
Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis
Z Yu, F Reynaud, M Lorscheider… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects 0.5–1% of the world
population. Current treatments include on one hand non‐steroidal anti‐inflammatory drugs …
population. Current treatments include on one hand non‐steroidal anti‐inflammatory drugs …